Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the use of Acthar in patients to undergo renal transplantation and will measure the rate of FSGS recurrence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Georgetown University; University of Colorado, Denver
• Treatments: Adrenocorticotropic Hormone

Criteria

Inclusion Criteria:

• FSGS

• To receive either a live donor or deceased donor kidney transplant

Exclusion Criteria:

• Not having FSGS